ACTIVE

MD Pharma

Financial year 2025 · closed on 31/12/2025
Net result
257,1 k €
-16.5% YoY
Gross margin
891,5 k €
+0.6% YoY
Equity
1,8 M €
+16.8% YoY

What does MD Pharma do?

MD Pharma is a Public limited company incorporated in 2016. Its main activity is: Leasing of intellectual property and similar products, except copyrighted works. Its registered office is in Gent.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0667.779.672
Incorporation
16/12/2016
Legal form
Public limited company
Registered office
Kortrijksesteenweg 1091 box B
9051 Gent · FlandreSee on map
Contributed capital
1 087 000,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 8 financial years

20252024202320222021202020192017
Income statement
Gross margin891,5 k €886,2 k €884,6 k €884,9 k €894,1 k €906,3 k €853,8 k €444 k €
EBITDA890,3 k €885,1 k €884,4 k €884,7 k €898,3 k €903,6 k €852,2 k €268,3 k €
Operating result369,7 k €364,5 k €363,2 k €364,2 k €373,1 k €378 k €319,1 k €-68,8 k €
Net result257,1 k €307,9 k €305,1 k €236 k €-48,8 k €-107,2 k €-129,4 k €-357,7 k €
Balance sheet
Equity1,8 M €1,5 M €1,2 M €921 k €685 k €733,8 k €841 k €-257,7 k €
Total assets2,7 M €1,9 M €1,6 M €2,1 M €3,4 M €7,4 M €7,1 M €4,4 M €
Cash4,9 k €14,7 k €4,4 k €56,1 k €829,3 k €49,4 k €63,3 k €27 k €
Debts650,4 k €197 k €196,1 k €1,1 M €2,7 M €6,5 M €6,2 M €4,6 M €
Other
Workforce3,3 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 9 ended

Active mandates

Aquitania

Director · since 30 mars 2026 · until 04 juin 2032 · 0666.678.822

Represented by Anja Imschoot

Active
MD CONSULT

Director · since 30 mars 2026 · until 04 juin 2032 · 0471.608.456

Represented by Mario Debel

Active

Ended mandates

Aquitania

Director · since 29 avril 2019 · until 06 juin 2025 · 0666.678.822

Represented by Anja Imschoot

Ended
Aquitania

Director · since 29 avril 2019 · until 30 juin 2025 · 0666.678.822

Represented by Anja Imschoot

Ended
Aquitania

Director · since 29 avril 2019 · 0666.678.822

Represented by Anja Imschoot

Ended
Aquitania

Director · since 29 avril 2019 · 0666.678.822

Represented by Anja Imschoot

Ended
At this address

Other companies at this address

CompanyCBE no.
2PHARMAActive
0886.662.746
2PHARMA HOLDINGActive
0644.751.377
0474.817.869
0893.541.630
Ceres InvestActive
0775.683.264
Ceres PharmaActive
0641.953.324
0407.326.754
CONESSENCEActive
0819.266.552
0794.812.555
0681.915.443
CREDOPHARActive
0849.730.193
DGPharmaActive
0508.925.544
DRIEPUNTNULActive
1021.711.292
HR ESSENTIALSActive
0721.702.467
KOUTERLOSActive
0450.036.349
LabopharActive
0643.723.177
PADEL FACTORYActive
0801.951.260
0865.651.952
0884.649.304
0421.364.139
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/07/202630/07/202525/07/202431/08/202320/07/202204/06/2021
General meeting30/06/202630/06/202530/06/202429/08/202324/06/202204/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

9 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202630/07/2026DutchPDF
Abridged model31/12/202430/06/202530/07/2025DutchPDF
Abridged model31/12/202330/06/202425/07/2024DutchPDF
Abridged model31/12/202229/08/202331/08/2023DutchPDF
Abridged model31/12/202124/06/202220/07/2022DutchPDF
Abridged model31/12/202004/06/202104/06/2021DutchPDF
Abridged model31/12/201921/08/202025/08/2020DutchPDF
Abridged model31/12/201822/08/201930/08/2019DutchPDF
Abridged model31/12/201722/08/201828/08/2018DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 9 ended

Active mandates

Aquitania

Director · since 30 mars 2026 · until 04 juin 2032 · 0666.678.822

Represented by Anja Imschoot

Active
MD CONSULT

Director · since 30 mars 2026 · until 04 juin 2032 · 0471.608.456

Represented by Mario Debel

Active

Ended mandates

Aquitania

Director · since 29 avril 2019 · until 06 juin 2025 · 0666.678.822

Represented by Anja Imschoot

Ended
Aquitania

Director · since 29 avril 2019 · until 30 juin 2025 · 0666.678.822

Represented by Anja Imschoot

Ended
Aquitania

Director · since 29 avril 2019 · 0666.678.822

Represented by Anja Imschoot

Ended
Aquitania

Director · since 29 avril 2019 · 0666.678.822

Represented by Anja Imschoot

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates29/04/2026
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office15/02/2022
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates16/12/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates09/05/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring21/12/2018
    BENAMING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring21/12/2018
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring21/12/2018
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring08/10/2018
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025257,1 k €
  2. 2024
    Annual accounts 2024307,9 k €
  3. 2023
    Annual accounts 2023305,1 k €
  4. 2022
    Annual accounts 2022236 k €
  5. 2021
    Annual accounts 2021-48,8 k €
  6. 2020
    Annual accounts 2020-107,2 k €
  7. 2019
    Annual accounts 2019-129,4 k €
  8. 2017
    Annual accounts 2017-357,7 k €
  9. 16/12/2016
    IncorporationPublic limited company